Feasibility, Reliability and Therapeutic Implications of Cytological Stained Smears as a Source of Starting Material for Next-Generation Sequencing-Based Molecular Testing in NSCLC Patients

被引：0
|
作者：
Lozano, Maria [1 ]
Abengozar, Marta [2 ]
Alvarez, Maria [3 ]
Echeveste, Jose [4 ]
Helena Royuela, Eva [3 ]
Garcia Tobar, Laura [3 ]
Joaquin Paricio, Jose [3 ]
Argueta, Allan [3 ]
Garcia Porrero, Guillermo [4 ]
Moreno, Marcela [5 ]
Gomez, Nerea [4 ]
de Andrea, Carlos [3 ]
机构：
[1] Univ Navarra, Pamplona, Spain
[2] Univ Navarra, Zizur Mayor, Spain
[3] Univ Navarra, Navarra, Spain
[4] Clin Univ Navarra, Navarra, Spain
[5] Univ Los Andes, Santiago, Chile
来源：
LABORATORY INVESTIGATION | 2020年 / 100卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
396
引用
收藏
页码：391 / 392
页数：2
相关论文
共 30 条
  • [1] Feasibility, Reliability and Therapeutic Implications of Cytological Stained Smears as a Source of Starting Material for Next-Generation Sequencing-Based Molecular Testing in NSCLC Patients
    Lozano, Maria
    Abengozar, Marta
    Alvarez, Maria
    Echeveste, Jose
    Helena Royuela, Eva
    Garcia Tobar, Laura
    Joaquin Paricio, Jose
    Argueta, Allan
    Garcia Porrero, Guillermo
    Moreno, Marcela
    Gomez, Nerea
    de Andrea, Carlos
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 391 - 392
  • [2] Cytology Smears as Excellent Starting Material for Next-Generation Sequencing-Based Molecular Testing of Patients With Adenocarcinoma of the Lung
    Velizheva, Nadezda P.
    Rechsteiner, Markus P.
    Wong, Christine E.
    Zhong, Qing
    Rossle, Matthias
    Bode, Beata
    Moch, Holger
    Soltermann, Alex
    Wild, Peter J.
    Tischler, Verena
    CANCER CYTOPATHOLOGY, 2017, 125 (01) : 30 - 40
  • [3] Feasibility and Reliability of Next Generation Sequencing in Cytological Stained Smears in Non-Small-Cell Lung Cancer
    Lozano Escario, Maria Dolores
    Abengozar, Marta
    Mejias, Luis
    Panadero, Pablo
    Joaquin Paricio, Jose
    Garcia Tobar, Laura
    Patino Garcia, Ana
    Amada Maset, Maria
    Idoate, Miguel
    Echeveste, Jose I.
    de Andrea, Carlos
    LABORATORY INVESTIGATION, 2018, 98 : 158 - 158
  • [4] Feasibility and Reliability of Next Generation Sequencing in Cytological Stained Smears in Non-Small-Cell Lung Cancer
    Lozano Escario, Maria Dolores
    Abengozar, Marta
    Mejias, Luis
    Panadero, Pablo
    Joaquin Paricio, Jose
    Tobar, Laura Garcia
    Patino Garcia, Ana
    Amada Maset, Maria
    Idoate, Miguel
    Echeveste, Jose I.
    de Andrea, Carlos
    MODERN PATHOLOGY, 2018, 31 : 158 - 158
  • [5] Next-generation sequencing-based testing for cancer mutational landscape diversity: clinical implications?
    Katsios, Christos
    Papaloukas, Costas
    Tzaphlidou, Margaret
    Roukos, Dimitrios H.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2012, 12 (07) : 667 - 670
  • [6] Next-generation sequencing-based molecular diagnosis of neuromuscular patients: results of three years experience
    Van Ghelue, M.
    Fagerheim, T.
    Hansen, G.
    Nygard, B.
    Arntzen, K.
    Orstavik, K.
    Rasmussen, M.
    Nilssen, O.
    Jonsrud, C.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S181 - S181
  • [7] Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
    Alicia Scocchia
    Tiia Kangas-Kontio
    Melita Irving
    Matti Hero
    Inka Saarinen
    Liisa Pelttari
    Kimberly Gall
    Satu Valo
    Johanna M. Huusko
    Jonna Tallila
    Johanna Sistonen
    Juha Koskenvuo
    Tero-Pekka Alastalo
    Orphanet Journal of Rare Diseases, 16
  • [8] Diagnostic utility of next-generation sequencing-based panel testing in 543 patients with suspected skeletal dysplasia
    Scocchia, Alicia
    Kangas-Kontio, Tiia
    Irving, Melita
    Hero, Matti
    Saarinen, Inka
    Pelttari, Liisa
    Gall, Kimberly
    Valo, Satu
    Huusko, Johanna M.
    Tallila, Jonna
    Sistonen, Johanna
    Koskenvuo, Juha
    Alastalo, Tero-Pekka
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [9] Subjecting appropriate lung adenocarcinoma samples to next-generation sequencing-based molecular testing: challenges and possible solutions
    Li, Weihua
    Qiu, Tian
    Ling, Yun
    Gao, Shugeng
    Ying, Jianming
    MOLECULAR ONCOLOGY, 2018, 12 (05) : 677 - 689
  • [10] Development of a Quality Assurance Framework for Clinical Reporting of. Next-Generation Sequencing-Based Molecular Oncology Testing
    Patel, K. P.
    Patel, K. P.
    Routbort, M.
    Aldape, K.
    Broaddus, R.
    Lazar, A.
    Chowdhuri, S. Roy
    Rashid, A.
    Singh, R.
    Zuo, Z.
    Chen, H.
    Shamanna, R. Kanagal
    Goswami, R.
    Jabbar, K.
    Barkoh, B.
    Manekia, J.
    Medeiros, L.
    Luthra, R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 778 - 778
123